QA: Kura Oncology Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2023_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001422143, Kura Oncology Inc.

  xvar xval
0 AssetsCurrent 446,426,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,540,000
3 remainder_Assets 7,340,000
4 LiabilitiesCurrent 24,057,000
5 LiabilitiesNoncurrent 11,971,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 47,053,000
9 ResearchAndDevelopmentExpense 92,812,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 4,025,000
13 remainder_ComprehensiveNetIncome -6,243,000
  yvar yval
0 Assets 456,306,000
1 Liabilities 36,028,000
2 Expenses 139,865,000
3 Revenues 0
4 StockholdersEquity 420,278,000
5 NetIncome -135,840,000
6 ComprehensiveNetIncome -138,961,500
7 BaseVar 321,233,500
8 EconomicCapitalRatio 2.37

Edgar->Model Mapping

Feature Distribution

Change over Time